Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Status:
Completed
Trial end date:
1991-03-01
Target enrollment:
Participant gender:
Summary
A controlled clinical trial was conducted at eight participating centers between January 1,
1988, and March 31, 1991. Patients were randomly assigned to an intravenous immune globulin
group or a control group. There were two phases to the study (see below). During phase 1 the
control infants received infusions of placebo. During phase 2 the control infants received no
infusion therapy.